Investigation of PSMB5 mutations in multiple myeloma

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00018926

Enrollment

100

Registered

2020-01-29

Start date

2020-01-30

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C90.0

Interventions

Group 1: Samples from patients with multiple myeloma will be analysed for mutations in PSMB5 (peripheral blood and bone marrow samples).

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Informed consent.

Exclusion criteria

Exclusion criteria: Missing informed consent. Active viral Hepatitis oder HIV.

Design outcomes

Primary

Measure	Time frame
Identification of mutations in PSMB5 in multiple myeloma	—

Countries

Germany

Contacts

Public ContactRoman-Ulrich Müller

Klinik II für Innere Medizin Uniklinik Köln

roman-ulrich.mueller at uk-koeln.de004922147886288

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026